The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone (Cancer Cell International)

Simplistic two-dimensional (2D) in vitro assays have long been the standard for studying the metastatic abilities of cancer cells. However, tri-dimensional (3D) organotypic models provide a more complex enviro...